| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4   |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
 | DroneDeploy | Industrial Industrial Software | Low | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $153.29M | Series E-1 | 9/9/2025 | $15M | $610.65M | $9.01 | Emergence Capital, Scale Venture Partners, Airtree Ventures, Bessemer Venture Partners, Uncork Capital | ||||
 | Forge Global | Fintech Capital Markets | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $285.92M | Series B-2 | 4/12/2021 | $1.64M | $627.56M | $12.42 | Wells Fargo | ||||
 | Mirantis | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $176.15M | Series X | 11/12/2019 | $15M | $702.22M | $3.70 | Undisclosed Investors | ||||
 | Neurona Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $342.29M | Series F | 4/3/2025 | $101.71M | $578.63M | $2.06 | Fidelity, The Column Group, Soleus Capital, Viking Global Investors, Cormorant Asset Management, Schroders Capital, LYFE Capital, Euclidean Capital, UCB Ventures, Willett Advisors, UC Investments, YK Bioventures, Berkeley Frontier Fund, Ysios Capital, Alexandria Venture Investments, Spur Capital Partners | ||||
 | Paige | Healthcare Healthcare Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $247.3M | Series C-1 | 3/2/2023 | $19.5M | $656.14M | $25.74 | Undisclosed Investors | ||||
 | Superhuman | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $125.93M | Series C | 8/4/2021 | $75M | $825M | $27.21 | IVP, Tiger Global, Drew Houston, Timothy Young, Jason Citron, Henrique Dubugras, Arianna Huffington, Ashton Kutcher, Will Smith, Mantis VC, 7BC Venture Capital, Acronym Venture Capital, Arceau Capital, Boldstart Ventures, Leyden Ventures, Quiet Capital, Reform Ventures, Top Tier Capital Partners | ||||
 | C2FO | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $490.31M | Series I | 4/14/2025 | $30.72M | $854.03M | $11.18 | International Finance Corporation | ||||
 | Capstan Therapeutics | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $845M | Series B | 3/20/2024 | $175M | $525.33M | $3.37 | RA Capital Management, Forbion, Johnson & Johnson, Mubadala Capital, Perceptive Advisors, Sofinnova Investments, Alexandria Venture Investments, Bristol Myers Squibb, Eli Lilly, Bayer, Novartis Venture Fund, OrbiMed, Pfizer Ventures, Polaris Partners, Vida Ventures | ||||
 | Jaunt | Industrial Augmented / Virtual Reality | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $177.08M | Series D | 2/21/2017 | $75M | $628.44M | $12.80 | Undisclosed Investors | ||||
 | Ribbon Home | Real Estate Real Estate Products & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $134.4M | Series C | 6/29/2021 | $80M | $507.45M | $16.05 | Undisclosed Investors | ||||
 | Beam Benefits | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $293.18M | Series F-1 | 7/24/2025 | $87.26M | $644.83M | $48.36 | Trinity Capital | ||||
 | Buf | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $93.46M | Series B | 12/7/2021 | $68M | $830.83M | $7.83 | Lux Capital, Tiger Global Management, Greenoaks Capital Partners, Lightspeed Venture Partners, Addition, Haystack Ventures | ||||
 | Cybereason | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $851.87M | Series H | 3/10/2025 | $120M | $806.28M | $0.63 | SoftBank, Liberty Strategic Capital | ||||
 | Rivos | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $376M | Series A-3 | 4/16/2024 | $250M | $758.96M | $1.95 | Matrix Capital Management, Intel Capital, MediaTek, Cambium Capital Management, CIDC, Capital TEN, Hotung Venture Capital, Walden Catalyst, Dell Technologies Capital, Koch Disruptive Technologies, VentureTech Alliance | ||||
 | Enfabrica | Technology Hardware Computing Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $259.39M | Series C | 11/19/2024 | $115M | $591.69M | $2.86 | Spark Capital, Arm Holdings, Cisco Investments, Maverick Silicon, Samsung, VentureTech Alliance, Atreides Management, Alumni Ventures, IAG Capital Partners, Liberty Global Ventures, Sutter Hill Ventures, Valor Equity Partners | ||||
 | Aisera | Enterprise Software Productivity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $517.36M | Series D-1 | 8/3/2022 | $30M | $622.62M | $3.86 | Goldman Sachs, Thoma Bravo, True Ventures, Menlo Ventures, Norwest Venture Partners, Icon Ventures, World Innovation Lab, Zoom Ventures, Khosla Ventures, First Round Capital, Maynard Webb, Silicon Valley Bank | ||||
 | Candid Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $370M | Series B | 9/9/2024 | $190.26M | $660.51M | $1.20 | Venrock, Fairmount Partners, TCG Crossover Management, venBio Partners, Foresite Capital, Third Rock Ventures, Fidelity, Samsara BioCapital, Qiming Venture Partners, OrbiMed, Boxer Capital, Redmile Group, Vida Ventures, Two River, Franklin Templeton, LifeSci Venture Partners, Mirae Asset Capital Life Science, Polaris Partners, Soleus Capital | ||||
 | Jackpocket | Consumer & Lifestyle Entertainment | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $220.06M | Series D-3 | 11/22/2022 | $20M | $780.37M | $4.84 | Undisclosed Investors | ||||
 | Alma | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $441.06M | Series D | 8/25/2022 | $130M | $788.56M | $17.52 | Thoma Bravo, Cigna Ventures, Insight Partners, Optum Ventures, Tusk Venture Partners, Primary Venture Partners, Sound Ventures | ||||
 | Metronome | Enterprise Software Data Intelligence | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $148.23M | Series C-1 | 6/18/2025 | $20M | $525.13M | $18.45 | -- | ||||
 | Plastiq | Fintech Payments | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $407.39M | Series E | 1/31/2022 | $34.7M | $713.51M | $9.75 | Accomplice, Wildcat Capital Management | ||||
 | Securiti | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $151.74M | Series C | 3/14/2023 | $77M | $575M | $7.92 | Owl Rock Capital, General Catalyst, Mayfield Fund, Capital One Ventures, Citi Ventures | ||||
 | Blue Jeans Network | Enterprise Software Communication & Collaboration Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $176.59M | Series E | 9/23/2015 | $76.5M | $713.32M | $12.29 | New Enterprise Associates, Deutsche Telekom Capital Partners, Glynn Capital Management, Jeter Ventres, Quadrille Capital, Accel Partners, Battery Ventures, Norwest Venture Partners | ||||
 | Carmot Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $594.61M | Series E | 5/25/2023 | $150M | $696.68M | $23.01 | Deep Track Capital, 5AM Ventures, Franklin Templeton, Frazier Life Sciences, Janus Henderson Investors, Millenium Management, TCGX, Venrock Healthcare Capital Partners, RA Capital Management, The Column Group, Willett Advisors | ||||